Video Experimental Relacionado
Updated: Jul 27, 2026
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
El papel de la interleucina 6 en la disfunción miocárdica del choque séptico por meningococo
Nazima Pathan1, Cheryl A Hemingway, Ash A Alizadeh
1Department of Paediatrics, Imperial College of Science, Technology and Medicine, W2 1PG, London, UK. n.pathan@imperial.ac.uk
Lancet (London, England)
|January 24, 2004
Resumen
La interleucina 6 (IL-6) causa depresión del miocardio en el choque séptico por meningococo. Esta citoquina inflamatoria es un factor clave en la disfunción cardíaca y la gravedad de la enfermedad, ofreciendo un potencial objetivo terapéutico.
Área de la Ciencia:
- Cardiología Cardiología.
- Inmunología Inmunología.
- Enfermedad Infecciosa Enfermedad Infecciosa.
Sus antecedentes:
- La insuficiencia miocárdica es crítica en el shock séptico, lo que lleva al daño de órganos y la mortalidad.
- La sepsis desencadena la liberación de factores que afectan la contractilidad del corazón.
- La identificación de estos depresores miocárdicos en el choque séptico meningocócico es crucial.
Objetivo del estudio:
- Para identificar mediadores específicos de la depresión del miocardio en el choque séptico por meningococos.
- Para investigar el papel de los factores séricos en la disfunción cardíaca inducida por la sepsis.
Principales métodos:
- Perfiles combinados de expresión génica, proteínas y análisis celulares.
- Se identificaron genes de regulación ascendente en la sangre después de la exposición a meningococos.
- Se seleccionaron proteínas estables al calor (12-25 kDa) como posibles factores depresores del miocardio.
Principales resultados:
- Se identificaron 174 genes regulados al alza; seis proteínas codificadas que coinciden con las características del factor depresor del miocardio.
- La interleucina 6 (IL-6) indujo una depresión miocárdica significativa in vitro.
- La eliminación de IL-6 abolió la actividad inotrópica negativa en el suero de los pacientes y en los supernatantes celulares.
- Los niveles séricos de IL-6 se correlacionan con la disfunción miocárdica y la gravedad de la enfermedad en niños.
Conclusiones:
- La interleucina 6 es un mediador clave de la depresión del miocardio en la enfermedad meningocócica.
- La IL-6 y sus vías aguas abajo representan objetivos terapéuticos potenciales para el shock séptico meningocócico.
Videos de Conceptos Relacionados
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...